Showing results (1781-1790 of 2,591) with videos related to

Sort By:
Pageof 260
Advances in Therapy|October 20, 2006
Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical settingEric R Braverman, Thomas J H Chen, John Schoolfield, et al.
Headache|April 2, 2015
Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eyeKrista I Kinard, A Gordon Smith, J Robinson Singleton, et al.
Anticancer Research|November 2, 2010
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)Wu Zhang, Mizutomo Azuma, Georg Lurje, et al.
Journal of Biomechanics|March 18, 2025
The impact of craft type on operational spine postures in military boat operatorsJoseph A Gordon, Zachary G Brumm, Bahar Shahidi, et al.
Neurobiology of Aging|October 30, 2016
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's diseaseMarissa Natelson Love, David G Clark, J Nicholas Cochran, et al.
Transplantation|September 28, 2004
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effectsThomas G Peters, Kristin N Spinola, John C West, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathologyBrian A Gordon, Austin McCullough, Shruti Mishra, et al.
Journal of Gerontological Nursing|July 4, 2018
Enabling Advance Directive Completion: Feasibility of a New Nurse-Supported Advance Care Planning InterventionMichelle M Hilgeman, Constance R Uphold, Amber N Collins, et al.
Advances in Therapy|February 6, 2007
Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variantKenneth Blum, Thomas J H Chen, Brian Meshkin, et al.
British Journal of Cancer|July 29, 2010
Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75M C Ryan, H Kostner, K A Gordon, et al.
Pageof 260